
Alaunos Therapeutics, Inc.
Alaunos Therapeutics, Inc.(TCRT)内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签;可在本季度与近12个月之间切换;下方为季度图与交易明细。
SEC EDGAR · FMP · TCRT · 截至 2026年6月9日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
0
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Alaunos Therapeutics, Inc.内部人在过去近12个月买卖活动混合。
▸ 数据来源:SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
TCRT 季度内部人买卖趋势
TCRT 内幕交易卖出 · TCRT 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源:SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
活跃内部人
近12个月交易最活跃 · TCRT CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
TCRT 高管卖出股份 · TCRT 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 22, 2026 | Weis Holger CEO | Award | 3,700 | $9K | Form 4 |
| Apr 29, 2026 | Vieser Jaime Director | Award | 6,515 | $17K | Form 4 |
| Apr 29, 2026 | Postma Robert W Director | Award | 6,274 | $16K | Form 4 |
| Apr 29, 2026 | Jerman Michael Allen Director | Award | 6,032 | $16K | Form 4 |
| Jan 12, 2026 | Jerman Michael Allen Director | Award | 5,406 | $16K | Form 4 |
| Jan 12, 2026 | Postma Robert W Director | Award | 5,622 | $16K | Form 4 |
| Jan 12, 2026 | Vieser Jaime Director | Award | 5,839 | $17K | Form 4 |
| Nov 21, 2025 | Vieser Jaime Director | Award | 5,340 | $17K | Form 4 |
| Nov 21, 2025 | Postma Robert W Director | Award | 5,142 | $16K | Form 4 |
| Nov 21, 2025 | Jerman Michael Allen Director | Award | 4,183 | $13K | Form 4 |
| Aug 18, 2025 | Groenewald Ferdinand Vice President of Finance | Award | 10,775 | — | Form 4 |
| Jul 3, 2025 | Postma Robert W Director | Award | 4,050 | — | Form 4 |
| Jul 3, 2025 | Vieser Jaime Director | Award | 3,400 | — | Form 4 |
| Apr 13, 2025 | Postma Robert W Director | Award | 20,804 | $61K | Form 4 |
| Apr 13, 2025 | Vieser Jaime Director | Award | 17,465 | — | Form 4 |
| Dec 31, 2024 | Vieser Jaime Director | Sale | 2,182 | $4K | Form 4 |
| Dec 31, 2024 | Vieser Jaime Director | Sale | 818 | $2K | Form 4 |
| Sep 1, 2023 | Boyle Kevin S. Sr. CEO · Director | Sale | 68,014 | $10K | Form 4 |
| Nov 29, 2022 | Postma Robert W Director | Purchase | 750,000 | $488K | Form 4 |
| Nov 29, 2022 | Vieser Jaime Director | Purchase | 1,250,000 | $813K | Form 4 |
| Aug 30, 2022 | Boyle Kevin S. Sr. CEO | Other | 18,750 | $45K | Form 4 |
| Jun 22, 2022 | Thistle Mary Director | Award | 40,000 | — | Form 4 |
| Jun 22, 2022 | Huang James Director | Award | 80,000 | — | Form 4 |
| Jun 22, 2022 | Postma Robert W Director | Award | 40,000 | — | Form 4 |
| Dec 22, 2021 | De Groot Eleanor EVP, Operations | Sale | 20,132 | $26K | Form 4 |
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源:SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 TCRT 内幕交易
TCRT 内幕交易
Alaunos Therapeutics, Inc.(TCRT)内幕交易数据来源于公司内部人(包括Vieser Jaime (Director), Postma Robert W (Director), Jerman Michael Allen (Director))提交的SEC Form 4申报文件。过去12个月内,5位内部人向SEC提交了交易申报。TCRT内部人近期买卖活动混合,这可能反映预设的10b5-1计划执行,而非方向性判断。
如需查看Alaunos Therapeutics, Inc.机构持仓比例和内部人持股百分比,请访问持仓(Ownership)标签页 → Ownership tab →
常见问题
TCRT 内幕交易 · 5个问题Alaunos Therapeutics, Inc.(TCRT)的内部人包括高管和董事,如Vieser Jaime (Director), Postma Robert W (Director), Jerman Michael Allen (Director)等。过去12个月内,5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源:FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026